Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model
- 1 March 2007
- Vol. 25 (11) , 2145-2154
- https://doi.org/10.1016/j.vaccine.2006.10.057
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cross-Clade Protection Induced by Human Immunodeficiency Virus-1 DNA Immunogens Expressing Consensus Sequences of Multiple Genes and Epitopes From Subtypes A, B, C, and FGHViral Immunology, 2005
- Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidateVaccine, 2005
- Genetic Immunization with Multiple HIV-1 Genes Provides Protection against HIV-1/MuLV Pseudovirus Challenge in vivoCells Tissues Organs, 2004
- Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodiesGene Therapy, 2004
- Defining Human Immunodeficiency Virus (HIV) Type 1 Immunotypes with Six Human Monoclonal AntibodiesAIDS Research and Human Retroviruses, 2004
- Mucosal Immunization with Inactivated Human Immunodeficiency Virus plus CpG Oligodeoxynucleotides Induces Genital Immune Responses and Protection against Intravaginal ChallengeThe Journal of Infectious Diseases, 2002
- HIV vaccine strategiesVaccine, 2002
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout MiceThe Journal of Experimental Medicine, 1997